Paid Clinical Trials in Mineola, NY

As of June 2026, 127 paid clinical trials are recruiting in Mineola, New York. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

127 clinical trials

↓ Download CSV

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

for Lumbar Spinal Stenosis

2306 locations incl. Athens

Sponsor: Stryker Instruments

Sex: All·Age: 18+

Code: NCT03072927·Recruiting

Apply to this trial

PARTNER 3 Trial - Aortic Valve-in-Valve

for Aortic Stenosis

50 locations incl. Phoenix

Sponsor: Edwards Lifesciences

Sex: All·Age: All ages

Code: NCT03003299·Recruiting

Apply to this trial

Improving the Quality of Care for Adults With Inflammatory Bowel Disease

for Crohn's Disease

29 locations incl. Los Angeles

Sponsor: Dartmouth-Hitchcock Medical Center

Sex: All·Age: 18 - 99

Code: NCT02791854·Enrolling By Invitation

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

245 locations incl. Birmingham

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting

Apply to this trial

Measuring Surgical Recovery After Radical Cystectomy

for Bladder Cancer

11 locations incl. San Francisco

Sponsor: M.D. Anderson Cancer Center

Sex: All·Age: 18+

Code: NCT03193970·Recruiting

Apply to this trial

Registry of Patients With Hypophosphatasia

for Hypophosphatasia (HPP)

20 locations incl. Centennial

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: All ages

Code: NCT02306720·Enrolling By Invitation

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

for Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma

Drug: Atezolizumab

338 locations incl. Birmingham

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT01810913·Phase 2, Phase 3·Recruiting

Apply to this trial